Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by National Resilience, Inc.
Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
February 20, 2024
From
National Resilience, Inc.
Via
Business Wire
National Resilience and Taiwan Bio-Manufacturing Corporation Announce Groundbreaking Partnership in Biomanufacturing Innovation
February 05, 2024
From
National Resilience, Inc.
Via
Business Wire
Resilience to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
National Resilience, Inc.
Via
Business Wire
Resilience Appoints Bill Marth as President of Services
November 07, 2023
From
National Resilience, Inc.
Via
Business Wire
BridgeBio and Resilience Announce Strategic Multi-Year Partnership to Advance BBP-631, BBP-812 and Future Gene Therapy Treatments
October 03, 2023
From
National Resilience, Inc.
Via
Business Wire
Tickers
BBIO
Resilience Announces Joint Venture with Lifera to Develop Manufacturing Facility in Saudi Arabia
August 28, 2023
From
National Resilience, Inc.
Via
Business Wire
Resilience Approved for $410M Financing from the Department of Defense, in Partnership with the Development Finance Corporation, to Establish Resilient Biomanufacturing Capacity
March 24, 2023
From
National Resilience, Inc.
Via
Business Wire
Resilience Signs Multi-Year Strategic Biomanufacturing Partnership with Leading Pharmaceutical Company
February 16, 2023
From
National Resilience, Inc.
Via
Business Wire
Resilience Announces Equity Investment from Mubadala and Funding of New Biopharma Manufacturing Facility in the United Arab Emirates
January 10, 2023
From
National Resilience, Inc.
Via
Business Wire
Resilience Becomes Biomanufacturing Resource Partner for California Institute for Regenerative Medicine
August 23, 2022
From
National Resilience, Inc.
Via
Business Wire
Resilience Announces Collaboration to Manufacture and Deliver Biotherapeutics for Rare and Complex Conditions
August 15, 2022
From
National Resilience, Inc.
Via
Business Wire
The Parker Institute for Cancer Immunotherapy and Resilience Announce Strategic Alliance to Develop Next-Generation Cancer Therapies
June 08, 2022
From
National Resilience, Inc.
Via
Business Wire
Resilience Announces $625 Million Series D Financing to Expand Network, Bring Innovative Technologies to Biomanufacturing
June 06, 2022
From
National Resilience, Inc.
Via
Business Wire
Resilience and MD Anderson Launch Joint Venture to Accelerate Development and Manufacturing of Innovative Cell Therapies for Cancer
June 02, 2022
From
National Resilience, Inc.
Via
Business Wire
Resilience Establishes Multi-Product Development and Manufacturing Collaboration with Takeda’s Plasma-Derived Therapies Business Unit
February 15, 2022
From
National Resilience, Inc.
Via
Business Wire
Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million from U.S. Department of Defense for Botulinum Neurotoxin Treatment
February 09, 2022
From
National Resilience, Inc.
Via
Business Wire
Resilience Acquires SwiftScale Biologics, a Leader in Cell-Free Protein Synthesis Technology
December 02, 2021
From
National Resilience, Inc.
Via
Business Wire
CORRECTING and REPLACING Resilience Joins Forces with Children’s Hospital of Philadelphia to Develop Next-Generation Biomanufacturing Technologies, Create Impactful Therapies
October 12, 2021
From
National Resilience, Inc.
Via
Business Wire
Resilience Joins Forces with Childen’s Hospital of Philadelpia to Develop Next-Generation Biomanufacturing Technologies, Create Impactful Therapies
October 12, 2021
From
National Resilience, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.